Evotec SE (EVO) Curent Deferred Tax Liability (2020 - 2026)
Evotec SE's (EVO) quarterly Curent Deferred Tax Liability came in at $8.2 million in Q2 2026, down 74.06% year-over-year from $31.7 million in Q2 2025, and down 8.97% quarter-over-quarter from $9.0 million in Q1 2026.
Analysis
Evotec SE (EVO) Curent Deferred Tax Liability (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Curent Deferred Tax Liability across 6 years of filings, most recently posting $8.2 million for Q2 2026.
- In Q2 2026, Curent Deferred Tax Liability fell 74.06% year-over-year to $8.2 million; the TTM figure through Jun 2026 stood at $8.2 million (down 74.06% YoY), while the FY2025 annual figure was $9.4 million, down 71.48% from the prior year.
- Curent Deferred Tax Liability came in at $8.2 million for Q2 2026 at Evotec SE, down from $9.0 million in the prior quarter.
- In the past five years, Curent Deferred Tax Liability ranged from a high of $32.7 million in Q4 2024 to a low of $517397.7 in Q1 2022.
- Average Curent Deferred Tax Liability over 4 years is $16.6 million, with a median of $10.2 million recorded in 2025.
- Year-over-year, Curent Deferred Tax Liability sank 70.23% in 2025 and plunged 74.06% in 2026.
- Over 4 years, Curent Deferred Tax Liability stood at $517397.7 in 2022, then soared by 6211.02% to $32.7 million in 2024, then slumped by 70.23% to $9.7 million in 2025, then decreased by 15.42% to $8.2 million in 2026.
- Per Business Quant data, the three most recent Curent Deferred Tax Liability figures were $8.2 million in Q2 2026, $9.0 million in Q1 2026, and $9.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | - |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 8.22 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.22 Mn |
| Mar 31, 2026 | 9.03 Mn |
| Dec 31, 2025 | 9.72 Mn |
| Sep 30, 2025 | 10.67 Mn |
| Jun 30, 2025 | 31.70 Mn |
| Mar 31, 2025 | 30.66 Mn |
| Dec 31, 2024 | 32.65 Mn |
| Mar 31, 2022 | 517,397.69 |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Dec 31, 2020 | 4.40 Mn |